REFERENCES
1. Schwechheimer C, Kuehn MJ. Outer-membrane vesicles from gram-negative bacteria: biogenesis and functions. Nat Rev Microbiol 2015;13:605-19.
2. Cecil JD, Sirisaengtaksin N, O'Brien-Simpson NM, Krachler AM. Outer membrane vesicle-host cell interactions. Microbiol Spectr 2019:7.
3. Toyofuku M, Nomura N, Eberl L. Types and origins of bacterial membrane vesicles. Nat Rev Microbiol 2019;17:13-24.
4. Olsen I, Amano A. Outer membrane vesicles - offensive weapons or good Samaritans? J Oral Microbiol 2015;7:27468.
5. Nagakubo T, Nomura N, Toyofuku M. Cracking open bacterial membrane vesicles. Front Microbiol 2019;10:3026.
6. Brown L, Wolf JM, Prados-Rosales R, Casadevall A. Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi. Nat Rev Microbiol 2015;13:620-30.
7. Huang Y, Nieh MP, Chen W, Lei Y. Outer membrane vesicles (OMVs) enabled bio-applications: a critical review. Biotechnol Bioeng 2022;119:34-47.
8. Wang S, Gao J, Wang Z. Outer membrane vesicles for vaccination and targeted drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2019;11:e1523.
9. Li Y, Wu J, Qiu X, et al. Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy. Bioact Mater 2023;20:548-60.
10. Alexander LM, van Pijkeren JP. Modes of therapeutic delivery in synthetic microbiology. Trends Microbiol 2023;31:197-211.
11. Alves NJ, Turner KB, Daniele MA, et al. Bacterial nanobioreactors-directing enzyme packaging into bacterial outer membrane vesicles. ACS Appl Mater Interfaces 2015;7:24963-72.
12. Yang D, Park SY, Lee SY. Production of rainbow colorants by metabolically engineered escherichia coli. Adv Sci 2021;8:e2100743.
13. Liu H, Geng Z, Su J. Engineered mammalian and bacterial extracellular vesicles as promising nanocarriers for targeted therapy. Extracell Vesicles Circ Nucleic Acids 2022;3:63-86.
14. Hu R, Li J, Zhao Y, et al. Exploiting bacterial outer membrane vesicles as a cross-protective vaccine candidate against avian pathogenic escherichia coli (APEC). Microb Cell Fact 2020;19:119.
15. Zanella I, König E, Tomasi M, et al. Proteome-minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform. J Extracell Vesicles 2021;10:e12066.
16. Thapa HB, Müller AM, Camilli A, Schild S. An intranasal vaccine based on outer membrane vesicles against SARS-CoV-2. Front Microbiol 2021;12:752739.
17. Li R, Liu Q. Engineered bacterial outer membrane vesicles as multifunctional delivery platforms. Front Mater 2020;7:202.
18. Kelwick R, MacDonald JT, Webb AJ, Freemont P. Developments in the tools and methodologies of synthetic biology. Front Bioeng Biotechnol 2014;2:60.
19. Brooks SM, Alper HS. Applications, challenges, and needs for employing synthetic biology beyond the lab. Nat Commun 2021;12:1390.
20. Voigt CA. Synthetic biology 2020-2030: six commercially-available products that are changing our world. Nat Commun 2020;11:6379.
21. Liew FE, Nogle R, Abdalla T, et al. Carbon-negative production of acetone and isopropanol by gas fermentation at industrial pilot scale. Nat Biotechnol 2022;40:335-44.
22. Kelwick RJR, Webb AJ, Freemont PS. Biological materials: the next frontier for cell-free synthetic biology. Front Bioeng Biotechnol 2020;8:399.
23. El Karoui M, Hoyos-Flight M, Fletcher L. Future trends in synthetic biology-a report. Front Bioeng Biotechnol 2019;7:175.
24. Carbonell P, Jervis AJ, Robinson CJ, et al. An automated design-build-test-learn pipeline for enhanced microbial production of fine chemicals. Commun Biol 2018;1:66.
25. Opgenorth P, Costello Z, Okada T, et al. Lessons from two design-build-test-learn cycles of dodecanol production in escherichia coli aided by machine learning. ACS Synth Biol 2019;8:1337-51.
26. Casas A, Bultelle M, Motraghi C, Kitney R. Removing the bottleneck: introducing cMatch - a lightweight tool for construct-matching in synthetic biology. Front Bioeng Biotechnol 2021;9:785131.
27. Sanders LM, Scott RT, Yang JH, et al. Biological research and self-driving labs in deep space supported by artificial intelligence. Nat Mach Intell 2023;5:208-19.
28. Beal J, Goñi-Moreno A, Myers C, et al. The long journey towards standards for engineering biosystems: are the molecular biology and the biotech communities ready to standardise? EMBO Rep 2020;21:e50521.
29. Kelly JR, Rubin AJ, Davis JH, et al. Measuring the activity of BioBrick promoters using an
30. Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 2018;7:1535750.
31. Dauros Singorenko P, Chang V, Whitcombe A, et al. Isolation of membrane vesicles from prokaryotes: a technical and biological comparison reveals heterogeneity. J Extracell Vesicles 2017;6:1324731.
32. Jessop-Fabre MM, Sonnenschein N. Improving reproducibility in synthetic biology. Front Bioeng Biotechnol 2019;7:18.
33. Gilman J, Walls L, Bandiera L, Menolascina F. Statistical design of experiments for synthetic biology. ACS Synth Biol 2021;10:1-18.
34. Beardall WAV, Stan GB, Dunlop MJ. Deep learning concepts and applications for synthetic biology. GEN Biotechnol 2022;1:360-71.
35. Eastwood TA, Baker K, Streather BR, et al. High-yield vesicle-packaged recombinant protein production from
36. Tao S, Chen H, Li N, Liang W. The application of the CRISPR-cas system in antibiotic resistance. Infect Drug Resist 2022;15:4155-68.
37. Porto EM, Komor AC, Slaymaker IM, Yeo GW. Base editing: advances and therapeutic opportunities. Nat Rev Drug Discov 2020;19:839-59.
38. Qi LS, Larson MH, Gilbert LA, et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 2013;152:1173-83.
39. Ceroni F, Boo A, Furini S, et al. Burden-driven feedback control of gene expression. Nat Methods 2018;15:387-93.
40. Tian H, Li B, Xu T, et al. Outer membrane vesicles derived from salmonella enterica serotype typhimurium can deliver shigella flexneri 2a O-polysaccharide antigen to prevent shigella flexneri 2a infection in mice. Appl Environ Microbiol 2021;87:e0096821.
41. Gasperini G, Alfini R, Arato V, et al. Salmonella paratyphi a outer membrane vesicles displaying vi polysaccharide as a multivalent vaccine against enteric fever. Infect Immun 2021:89.
42. Plahar HA, Rich TN, Lane SD, et al. Bioparts-a biological parts search portal and updates to the ICE parts registry software platform. ACS Synth Biol 2021;10:2649-60.
43. Haines MC, Carling B, Marshall J, et al. Basicsynbio and the BASIC SEVA collection: software and vectors for an established DNA assembly method. Synth Biol 2022;7:ysac023.
44. Kelwick RJR, Webb AJ, Heliot A, Segura CT, Freemont PS. Opportunities to accelerate extracellular vesicle research with cell‐free synthetic biology. J of Extracellular Bio 2023;2:e90.
45. Jumper J, Evans R, Pritzel A, et al. Highly accurate protein structure prediction with AlphaFold. Nature 2021;596:583-9.
46. Lin Z, Akin H, Rao R, et al. Evolutionary-scale prediction of atomic-level protein structure with a language model. Science 2023;379:1123-30.
47. Wang J, Lisanza S, Juergens D, et al. Scaffolding protein functional sites using deep learning. Science 2022;377:387-94.
48. Dauparas J, Anishchenko I, Bennett N, et al. Robust deep learning-based protein sequence design using ProteinMPNN. Science 2022;378:49-56.
49. Zawada JF, Burgenson D, Yin G, et al. Cell-free technologies for biopharmaceutical research and production. Curr Opin Biotechnol 2022;76:102719.
50. Dumas A, Lercher L, Spicer CD, Davis BG. Designing logical codon reassignment - Expanding the chemistry in biology. Chem Sci 2015;6:50-69.
51. Young TS, Schultz PG. Beyond the canonical 20 amino acids: expanding the genetic lexicon. J Biol Chem 2010;285:11039-44.
52. Rezhdo A, Islam M, Huang M, Van Deventer JA. Future prospects for noncanonical amino acids in biological therapeutics. Curr Opin Biotechnol 2019;60:168-78.
53. Duffy K, Arangundy-Franklin S, Holliger P. Modified nucleic acids: replication, evolution, and next-generation therapeutics. BMC Biol 2020;18:112.
54. Xu C, Martin N, Li M, Mann S. Living material assembly of bacteriogenic protocells. Nature 2022;609:1029-37.
55. Lussier F, Staufer O, Platzman I, Spatz JP. Can bottom-up synthetic biology generate advanced drug-delivery systems? Trends Biotechnol 2021;39:445-59.
56. Chen C, Sun M, Wang J, et al. Active cargo loading into extracellular vesicles: Highlights the heterogeneous encapsulation behaviour. J Extracell Vesicles 2021;10:e12163.
57. Chen H, Zhou M, Zeng Y, et al. Recent advances in biomedical applications of bacterial outer membrane vesicles. J Mater Chem B 2022;10:7384-96.
